Protection by catatoxic steroids against dihydrotachysterol intoxication.
D045930:Anabolic Agents / Q000008:administration & dosage; D000736:Androstenes / Q000627:therapeutic use; D000818:Animals; D001011:Aorta / Q000473:pathology; D002114:Calcinosis / Q000139:chemically induced* / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D055598:Chemical Phenomena; D002621:Chemistry; D004097:Dihydrotachysterol / Q000633:toxicity*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006914:Hydroxysteroids / Q000627:therapeutic use; D007664:Ketosteroids / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced*; D009206:Myocardium / Q000473:pathology; D009397:Nephrocalcinosis / Q000401:mortality / Q000473:pathology / Q000517:prevention & control; D009654:Norsteroids / Q000627:therapeutic use; D011278:Pregnanes / Q000008:administration & dosage / Q000627:therapeutic use; D011283:Pregnenes / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use; D051381:Rats; D013256:Steroids / Q000627:therapeutic use*
D045930:Anabolic Agents; D000736:Androstenes; D005938:Glucocorticoids; D006914:Hydroxysteroids; D007664:Ketosteroids; D009654:Norsteroids; D011278:Pregnanes; D011283:Pregnenes; D011422:Propionates; D013256:Steroids; D004097:Dihydrotachysterol